Resource Utilization and Cost of Treatment with Anidulafungin or Fluconazole for Candidaemia and Other Forms of Invasive Candidiasis: Focus on Critically Ill Patients

By Reboli Annette C.  

PharmacoEconomics, Vol. 29, Iss. 8, 2011-08 ,pp. : 705-717

Adis International

Access to resources Recommend Favorite

Micafungin appears to be cost saving versus caspofungin when used to treat candidaemia and invasive candidiasis

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 589, 2009-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

Micafungin matches competitors in candidaemia and candidiasis

By  

Inpharma, Vol. 1, Iss. 1564, 2006-01 ,pp. : 15-16

Adis International

Access to resources Recommend Favorite

Anidulafungin improves outcome at no extra cost

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 633, 2011-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite

Anidulafungin

By David Murdoch   Greg L. Plosker  

Drugs, Vol. 64, Iss. 19, 2004-01 ,pp. : 2249-2258

Adis International

Access to resources Recommend Favorite